Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Systems Biology in Biotech & PharmaDevelopment: Multiscale CSB—Simulation Tools

Systems Biology in Biotech & Pharma: Development: Multiscale CSB—Simulation Tools [In order to cover bottom-up and top-down phenomena multiscale SB simulation tools should include organ-level considerations, and should be used in conjunction with multiscale modeling tools which have the ability to handle many orders of magnitude in both length and timescale. Several new R&D paradigms, based on CSB, are proposed, while some are already in the research stage. This effort will lead to virtual organ/disease models, emerging as important tools. Identifying and targeting a system’s emergent properties is a major goal for coming years. This will cause a paradigm shift in R&D activity in Pharma yielding a move from population models to models of individualized medicine. The importance of multiscale CSB is underlined here as a great attention is given here in this section.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

Systems Biology in Biotech & PharmaDevelopment: Multiscale CSB—Simulation Tools

Loading next page...
 
/lp/springer-journals/systems-biology-in-biotech-pharma-development-multiscale-csb-sMYtB3PAg6

References (46)

Publisher
Springer Netherlands
Copyright
© The Author(s) 2012
ISBN
978-94-007-2848-6
Pages
87 –102
DOI
10.1007/978-94-007-2849-3_8
Publisher site
See Chapter on Publisher Site

Abstract

[In order to cover bottom-up and top-down phenomena multiscale SB simulation tools should include organ-level considerations, and should be used in conjunction with multiscale modeling tools which have the ability to handle many orders of magnitude in both length and timescale. Several new R&D paradigms, based on CSB, are proposed, while some are already in the research stage. This effort will lead to virtual organ/disease models, emerging as important tools. Identifying and targeting a system’s emergent properties is a major goal for coming years. This will cause a paradigm shift in R&D activity in Pharma yielding a move from population models to models of individualized medicine. The importance of multiscale CSB is underlined here as a great attention is given here in this section.]

Published: Jan 4, 2012

Keywords: Cellular Automaton; Parkinson Disease; Emergent Property; Multiscale Model; Correlation Network

There are no references for this article.